BAC vs HAE Stock Comparison

HAE currently leads BAC in this stock comparison, with AIQ scores of 77 vs 56. The clearest difference is momentum, while BAC has the stronger risk resilience profile.

Market data as of Nov 18, 2026 market close· AIQ score gap 21 points
BAC
Financial Services
vs
HAE
Healthcare
BAC
Bank of America Corporation
Price
$48.91
Day move
-1.07%
AIQ Score
56/100
Best edge
Risk Resilience
Sector
Financial Services
HAE
Haemonetics Corporation
Leads
Price
$123
Day move
+1.6%
AIQ Score
77/100
Best edge
Momentum
Sector
Healthcare

What is the main difference between BAC and HAE?

HAE leads the current stock comparison as Haemonetics Corporation, with the clearest separation coming from momentum and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Bank of America Corporation vs Haemonetics Corporation

Data as of Nov 18, 2026· market close· Cross-sector · Financial Services vs Healthcare· Coverage 65/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 7/10

HAE leads

HAE leads by 21 AIQ points, primarily on Momentum and Quality, and the lead has widened from 16 points over 30 sessions. Wall Street currently favors BAC on target upside.

Competitive: 3 of 6 evidence groups support HAE, its lead is widening, and its current signal state is conflicted.

Evidence agreement: 3 of 6Comparison trend: Strengthening
BAC

Bank of America Corporation

AIQ Score
56/100
AIQ Edge Score
6/10
HAE

Haemonetics Corporation

Leads
AIQ Score
77/100
AIQ Edge Score
10/10

The Algovestiq AIQ Score currently favors HAE over BAC, 77 versus 56 as of Nov 18, 2026. HAE's advantage is driven primarily by stronger momentum and quality, while BAC holds the stronger risk resilience profile. HAE also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors BAC. 3 of 6 covered evidence groups favor HAE today, and the comparison is rated Competitive on stability: only 3 of 6 covered evidence groups agree. HAE lead: Strengthening — the AIQ differential moved from 16 to 21 points over 30 sessions.

Compare Bank of America Corporation and Haemonetics Corporation across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

BAC
+19.5%
HAE
+122.9%

Total return comparison

Growth of $10,000, distributions reinvested

BAC $11,945 · HAE $22,290

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare BAC and HAE against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

BAC advantage
0
HAE advantage
  • Momentum34 vs 91
    HAE +57
  • Risk Resilience83 vs 67
    BAC +16
  • Quality64 vs 77
    HAE +13
  • Value65 vs 60
    BAC +5

3 of 6 evidence groups favor HAE. HAE’s edge is concentrated in momentum and quality; BAC keeps a meaningful risk resilience edge.

What changed since the last close

Latest scored session 2026-11-18, compared against the prior scored session 2026-11-17.

BAC-1 AIQ

Largest factor move: Value -3

New signals

  • OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
HAE0 AIQ

Largest factor move: Momentum -1, not enough on its own to move the overall score.

New signals

  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.64x)

HAE's lead widened by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — BAC and HAE both carry a full feed there.

The central trade-off

HAE (Haemonetics Corporation): the stronger current systematic profile, led by momentum and quality.

BAC (Bank of America Corporation): the counter-case, on risk resilience, value, valuation.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

HAE

HAE on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

HAE

HAE on combined revenue and EPS growth.

Value

BAC

BAC on the peer-relative Value factor, by 5 points.

Momentum

HAE

HAE on the Momentum factor, by 57 points.

Lower downside

BAC

BAC on Risk Resilience, by 16 points.

Analyst upside

BAC

BAC on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors HAE, analyst targets favor BAC. That disagreement is the most useful thing on this page.

MeasureBACHAENote
Implied upside to target+29.4%+14.1%BAC has more room
Target dispersion+25.3%+32.8%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering2512Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 6 covered evidence groups favor HAE. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreHAE56 vs 77
FundamentalsHAEon balancerevenue growth -3.3% vs 5.4%; EPS growth -23.8% vs 39.7%; TTM ROE 2.3% vs 5.2%; gross margin 60.4% vs 58.8%; operating margin 22.4% vs 18.3% — HAE takes 3 of 5 decided legs, not all of them
ValuationBACValue 65 vs 60
TechnicalsHAEPrice vs 50-day -9.5% vs 8.4%; vs 200-day -7% vs 51.3%
Risk ResilienceBACRisk Resilience 83 vs 67
Analyst expectationsBACTarget upside 29.4% vs 14.1%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BAC and HAE and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is wide at 21 points. (supports the conclusion holding)
  • Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The leader's advantage has been widening. (supports the conclusion holding)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on HAE.

How the comparison changed

120 daily snapshots · Jun 1 – Nov 18

HAE lead: Strengthening — the AIQ differential moved from 16 to 21 points over 30 sessions.

Jun 1BAC leads above the line · HAE leads belowNov 18
Today
HAE +21
56 vs 77
7 sessions ago
HAE +20
58 vs 78
30 sessions ago
HAE +16
62 vs 78
90 sessions ago
HAE +7
70 vs 77

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

BACConflicted

2 bullish / 2 bearish / 1 neutral, conflicted

Only BAC

  • Bollinger Band Squeeze — neutral, volatility, short horizon (4.5%)
  • Death Cross Active — bearish, trend, long horizon (1.45%)
  • Downtrend Structure Active — bearish, trend, long horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
  • OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
HAEConflicted

3 bullish / 1 bearish / 2 neutral, conflicted

Only HAE

  • Golden Cross Active — bullish, trend, long horizon (39.44%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (3.60%)
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.64x)
  • Uptrend Structure Active — bullish, trend, long horizon

HAE leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

BACConfirmed weakness

Price and the AIQ Score both moved down over the latest session (price -1.07%, AIQ -1 points).

HAENo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.6%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1BAC closes the Momentum gap — currently 57 points behind, the largest single contributor to HAE's edge.
  2. 2BAC's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3HAE's conflicting signal state resolves bearish — it currently carries 3 bullish and 1 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

HAE leads on balance
MetricBACHAE
Revenue growth (YoY)-3.3%5.4%
EPS growth (YoY)-23.8%39.7%
Gross margin60.4%58.8%
Operating margin22.4%18.3%
Return on equity (TTM)2.3%5.2%
Debt to equity1.281.25

Performance

HAE leads 5 of 6 windows
MetricBACHAE
1 week (5 sessions)3.2%2.5%
1 month (20 sessions)-0.4%3.9%
3 months (63 sessions)-20.1%36.2%
6 months (126 sessions)2.5%118.4%
Year to date-7.2%53.4%
1 year (252 sessions)-5.7%68.1%

Technicals

HAE has the stronger structure
MetricBACHAE
RSI (14)45.958.7
ADX (14)27.238.6
Price vs 50-day-9.5%8.4%
Price vs 200-day-7%51.3%
Volatility (1M, annualized)24.8%33.1%

Risk

BAC is the more resilient
MetricBACHAE
Beta0.790.24
Sharpe ratio-0.221.35
Sortino ratio-0.292.46
Max drawdown-23.7%-40.1%
Current drawdown-21.3%-3.5%
Annualized volatility22.4%41%
Value at risk (95%)-2.6%-3.1%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, BAC or HAE?

On the Algovestiq AIQ Score, HAE is the stronger of the two as of Nov 18, 2026, scoring 77 against BAC's 56. The edge comes from momentum and quality. BAC is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is BAC or HAE the better buy right now?

HAE carries the stronger systematic profile as of Nov 18, 2026, and the comparison is rated Competitive — 3 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor HAE over BAC?

The composite weights Quality, Value, Momentum and Risk Resilience. HAE leads Momentum by 57 points; BAC leads Risk Resilience by 16 points; HAE leads Quality by 13 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, BAC or HAE?

Analyst price targets imply +29.4% upside for BAC and +14.1% for HAE, so the Street currently favors BAC. That points the opposite way to the AIQ Score, which favors HAE. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, BAC or HAE?

BAC is the better-valued of the two on the peer-relative Value factor. BAC on the peer-relative Value factor, by 5 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, BAC or HAE?

HAE on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, BAC or HAE?

HAE on the Momentum factor, by 57 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, BAC or HAE?

BAC is the more resilient of the two, so the other name carries the higher downside risk. BAC on Risk Resilience, by 16 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is BAC more profitable than HAE?

The profitability evidence is mixed: gross margin 60.4% vs 58.8%; operating margin 22.4% vs 18.3%; ttm roe 2.3% vs 5.2%. BAC leads on two measures and HAE on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is HAE's lead over BAC getting stronger or weaker?

HAE lead: Strengthening — the AIQ differential moved from 16 to 21 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-01 and 2026-11-18. The lead has not changed hands in that window.

What would change the BAC vs HAE verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: BAC closes the Momentum gap — currently 57 points behind, the largest single contributor to HAE's edge; BAC's Death Cross Active resolves — a bearish trend rule currently active against it; HAE's conflicting signal state resolves bearish — it currently carries 3 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about BAC and HAE?

BAC: 2 bullish / 2 bearish / 1 neutral, conflicted. HAE: 3 bullish / 1 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BAC is Death Cross Active (bearish, long horizon). On HAE it is Golden Cross Active (bullish, long horizon).

Compare BAC and HAE with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.